Wealth Alliance Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.89M | Sell |
11,481
-3,156
| -22% | -$679K | 0.42% | 47 |
|
|
2026
Q1 | $3.18M | Buy |
14,637
+1,198
| +9% | +$266K | 0.5% | 40 |
|
|
2025
Q4 | $3.07M | Buy |
13,439
+31
| +0.2% | +$7.06K | 0.53% | 38 |
|
|
2025
Q3 | $3.1M | Buy |
13,408
+247
| +2% | +$50.3K | 0.56% | 39 |
|
|
2025
Q2 | $2.44M | Buy |
13,161
+3,047
| +30% | +$566K | 0.47% | 42 |
|
|
2025
Q1 | $2.12M | Buy |
10,114
+838
| +9% | +$163K | 0.44% | 44 |
|
|
2024
Q4 | $1.65M | Buy |
9,276
+1,656
| +22% | +$304K | 0.35% | 52 |
|
|
2024
Q3 | $1.5M | Buy |
7,620
+288
| +4% | +$53.8K | 0.32% | 57 |
|
|
2024
Q2 | $1.26M | Sell |
7,332
-370
| -5% | -$61.3K | 0.28% | 62 |
|
|
2024
Q1 | $1.4M | Sell |
7,702
-207
| -3% | -$35.7K | 0.33% | 52 |
|
|
2023
Q4 | $1.23M | Buy |
7,909
+6
| +0.1% | +$875 | 0.32% | 50 |
|
|
2023
Q3 | $1.18M | Sell |
7,903
-4,039
| -34% | -$593K | 0.35% | 48 |
|
|
2023
Q2 | $1.61M | Sell |
11,942
-376
| -3% | -$55.1K | 0.57% | 33 |
|
|
2023
Q1 | $1.96M | Buy |
12,318
+2,538
| +26% | +$388K | 0.73% | 26 |
|
|
2022
Q4 | $1.58M | Buy |
9,780
+224
| +2% | +$34.3K | 0.6% | 33 |
|
|
2022
Q3 | $1.28M | Buy |
9,556
+2,382
| +33% | +$342K | 0.57% | 36 |
|
|
2022
Q2 | $1.1M | Buy |
7,174
+532
| +8% | +$81.3K | 0.52% | 36 |
|
|
2022
Q1 | $1.08M | Buy |
6,642
+1,693
| +34% | +$246K | 0.47% | 39 |
|
|
2021
Q4 | $670K | Buy |
4,949
+272
| +6% | +$32.1K | 0.29% | 63 |
|
|
2021
Q3 | $505K | Buy |
4,677
+563
| +14% | +$64.3K | 0.25% | 69 |
|
|
2021
Q2 | $463K | Hold |
4,114
| – | – | 0.23% | 75 |
|
|
2021
Q1 | $445K | Sell |
4,114
-300
| -7% | -$32.1K | 0.23% | 73 |
|
|
2020
Q4 | $473K | Hold |
4,414
| – | – | 0.26% | 67 |
|
|
2020
Q3 | $387K | Sell |
4,414
-318
| -7% | -$29.9K | 0.23% | 67 |
|
|
2020
Q2 | $465K | Buy |
4,732
+174
| +4% | +$15.3K | 0.29% | 59 |
|
|
2020
Q1 | $347K | Buy |
4,558
+636
| +16% | +$54.2K | 0.27% | 67 |
|
|
2019
Q4 | $347K | Buy |
3,922
+18
| +0.5% | +$1.49K | 0.2% | 80 |
|
|
2019
Q3 | $287K | Sell |
3,904
-122
| -3% | -$8.36K | 0.18% | 85 |
|
|
2019
Q2 | $283K | Buy |
4,026
+100
| +3% | +$7.86K | 0.17% | 91 |
|
|
2019
Q1 | $306K | Buy |
3,926
+131
| +3% | +$10.7K | 0.2% | 82 |
|
|
2018
Q4 | $350K | Buy |
3,795
+1,013
| +36% | +$89.1K | 0.26% | 65 |
|
|
2018
Q3 | $263K | Buy |
2,782
+1
| +0% | +$95 | 0.13% | 110 |
|
|
2018
Q2 | $258K | Sell |
2,781
-1
| -0% | -$98 | 0.14% | 106 |
|
|
2018
Q1 | $263K | Buy |
+2,782
| New | +$306K | 0.15% | 92 |
|
Other funds holding ABBV
ECSS
ATO
Wealth Alliance Advisory Group's ABBV Position: Q2 2026 in Review
Wealth Alliance Advisory Group reduced its AbbVie (ABBV) stake by 22% in Q2 2026, selling an estimated $679K and leaving 11,481 shares worth $2.89M. The position accounts for 0.42% of the portfolio, ranked #47.
Wealth Alliance Advisory Group first reported a position in ABBV in Q1 2018 and has held it in 34 quarters since. The position peaked at $3.18M in Q1 2026. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Wealth Alliance Advisory Group held 11,481 shares of AbbVie worth $2.89M as of Q2 2026.
- Wealth Alliance Advisory Group sold 3,156 AbbVie shares in Q2 2026, an estimated $679K.
- AbbVie made up 0.42% of Wealth Alliance Advisory Group's portfolio in Q2 2026, its #47 holding.
- Wealth Alliance Advisory Group first reported a position in AbbVie in Q1 2018 and has held it in 34 quarters since.
- Wealth Alliance Advisory Group's AbbVie position peaked at $3.18M in Q1 2026.
- 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Wealth Alliance Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.